Results 101 to 110 of about 1,439 (152)

ORItavancin as a therapeutic regimen for Cardiac Implantable Electronic Devices infections with multidrug-resistant Gram-positive cocci (ORI-4-CIEDi) pilot study: rationale and design. [PDF]

open access: yesCardiol J
Łoboda D   +10 more
europepmc   +1 more source

A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Acute Bacterial Skin and Skin Structure Infections. [PDF]

open access: yesClin Infect Dis
Sutton KN   +12 more
europepmc   +1 more source

Delafloxacin Resistance and MIC-Distribution in Ciprofloxacin-Resistant Enterobacterales: A Retrospective Evaluation of Minimum Inhibitory Concentrations. [PDF]

open access: yesAntibiotics (Basel)
Forstner P   +8 more
europepmc   +1 more source

Population pharmacokinetics of dalbavancin: external validation, model averaging, and implications for precision dosing in prolonged therapy. [PDF]

open access: yesAntimicrob Agents Chemother
Sayadi H   +9 more
europepmc   +1 more source

Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials. [PDF]

open access: yesJ Antimicrob Chemother
Holland TL   +8 more
europepmc   +1 more source

A Comparative Review of the Pharmacology of Dalbavancin and Oritavancin for Gram-Positive Infections: Birds of a Feather or Apples and Oranges? [PDF]

open access: yesInfect Dis Ther
Hussein M   +11 more
europepmc   +1 more source

A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections. [PDF]

open access: yesPediatr Infect Dis J
Mngqibisa R   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy